Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.19 USD
Change Today +0.13 / 4.25%
Volume 104.2K
SZYM On Other Exchanges
As of 5:10 PM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).

solazyme inc (SZYM) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/16/15 - $4.74
52 Week Low
08/24/15 - $1.89
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SOLAZYME INC (SZYM)

solazyme inc (SZYM) Related Businessweek News

View More BusinessWeek News

solazyme inc (SZYM) Details

Solazyme, Inc. manufactures and sells renewable oils and other bioproducts. Its proprietary technology transforms a range of plant-based sugars into triglyceride oils and other bioproducts. The company offers renewable tailored oils, such as oleic oils that provide sustainable solutions within the food, lubricant, functional fluid, and oleo chemical markets; and drop-in replacements and blendstocks for marine, motor vehicle, and jet fuels, as well as replacements for petrochemicals, oleochemicals, and functional fluids. It also provides fuels, including SoladieselBD and SoladieselRD for on-road applications; ultra-low sulfur diesel; and Solajet for aviation use. In addition, the company offers microalgae-based food ingredients consisting of Tailored oils and powdered oils; and powdered ingredients comprising AlgaVia whole algal flour, AlgaVia whole algal protein, AlgaVia lipid powder, and encapsulated oils. Additionally, it provides skin and personal care products under the Algenist brand name, which include concentrated reconstructing serum, an anti-aging serum; complete eye renewal balm; firming and lifting cream, an anti-aging moisturizing cream; advanced anti-aging repairing oil, a face oil formulation; and genius cream. The company was incorporated in 2003 and is headquartered in South San Francisco, California.

266 Employees
Last Reported Date: 03/6/15
Founded in 2003

solazyme inc (SZYM) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $560.0K
Chief Financial Officer and Chief Operating O...
Total Annual Compensation: $410.4K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $335.0K
Chief Technology Officer
Total Annual Compensation: $370.8K
Strategic Advisor
Total Annual Compensation: $378.8K
Compensation as of Fiscal Year 2014.

solazyme inc (SZYM) Key Developments

Solazyme, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015; Provides Earnings Guidance for the Fourth Quarter and Full Year of 2015

Solazyme, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2015. For the quarter, the company reported total revenues of $11,399,000 compared to $17,559,000 a year ago. Loss from operations was $25,953,000 compared to $35,493,000 a year ago. Net loss was $34,918,000 or $0.43 per basic and diluted share compared to $39,677,000 or $0.50 per basic and diluted share a year ago. Net loss (non-GAAP) was $30,947,000 or $0.39 per basic and diluted share compared to $35,329,000 or $0.45 per basic and diluted share a year ago. The year over year decline in Revenue was due to expected decreases in funded program revenue and slower than anticipated adoption rates for Encapso lubricant. Quarterly operating cash burn was approximately $20 million for the quarter, down about 30% versus $29 million from third quarter last year, reflecting ongoing cost management initiatives. For the nine months, the company reported total revenues of $35,744,000 compared to $45,889,000 a year ago. Loss from operations was $78,582,000 compared to $100,166,000 a year ago. Net loss was $106,754,000 or $1.33 per basic and diluted share compared to $117,275,000 or $1.57 per basic and diluted share a year ago. Net loss (non-GAAP) was $92,197,000 or $1.15 per basic and diluted share compared to $97,881,000 or $1.31 per basic and diluted share a year ago. The company currently expects fourth quarter 2015 revenues to be up slightly from reported revenues in third quarter of 2015. With the expanded Solazyme-Bunge JV agreement and decision at Clinton and Galva, the company expects production will continue to be focused at Moema and Peoria facilities and that will begin to recognize Clinton/Galva cost savings in early 2016. Lastly, in line with previous guidance, the company expects a reduction in annual cash operating expenses for 2015.

Bunge and Solazyme Expands Joint Venture

Solazyme and Bunge Limited announced they have agreed to expand their joint venture to include a focus on food. The expansion includes a range of breakthrough oils for food and products for animal nutrition. The expanded joint venture will build on Solazyme’s ground-breaking microalgae innovation platform, and on Bunge’s global leadership in food and ingredients, including vegetable oils. As part of the JV expansion, the partners also entered into an agreement to expand their co-funded research programs to include new unique products in nutrition and specialty fats. Manufacturing will take place in the JV’s fully operational facility in São Paulo state, Brazil. As part of the agreement, AlgaWise Ultra Omega-9 Algae Oil, AlgaWise High Stability Algae Oil and AlgaWise Algae Butter structuring fats will be marketed by Bunge’s established global food oil sales and applications team, who bring strong expertise and a global footprint. In addition, Bunge will handle oil processing and supply chain aspects of commercialization. The expanded JV will manufacture and commercialize a range of new to the world, highly differentiated products, each providing breakthrough solutions to meet major needs in the food industry: AlgaWise Ultra Omega-9 Algae Oil is a clean tasting oil with the high level of monounsaturated fats (>90%) on the market and the lowest level of saturated fat of any food oil (<4%). This oil is ideal for meeting market demand for healthier alternatives to saturated fat oils, providing shelf-life stability and excellent culinary performance with one of the high smoke points available. AlgaWise High Stability Algae Oil delivers step change performance with one of the high stabilities of any oil on the market, over 87% monounsaturated fatty acids and only 2% polyunsaturates, less than any other food oil. High Stability Algae Oil drives unprecedented oxidative stability with zero trans-fat per serving. With an exceptionally neutral flavor and high stability under varying conditions, this is a high performance oil that works well in industrial frying, spraying/coating, pan spraying and blending. It can enable food manufacturers to remove added preservatives in everyday favorite foods such as dressings and mayonnaise, achieving cleaner labels with fewer ingredients, as well as completely removing partially hydrogenated vegetable oils. AlgaWise Algae Butter has a composition and functionality mirroring high value structuring fats such as shea stearin, with a high proportion of stearic-oleic-stearic triglycerides (approximately 70%). This unique oil can be used in a wide range of products. It is expected to have significant value in confectionery based on its reliable, scalable and sustainable supply, as well as offering a better performing alternative for bakery, confectionary, spreads and other applications. The product is expected to be available for the U.S. market in 2016.

Solazyme, Inc. to Report Q3, 2015 Results on Oct 30, 2015

Solazyme, Inc. announced that they will report Q3, 2015 results at 5:00 PM, Eastern Standard Time on Oct 30, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SZYM:US $3.19 USD +0.13

SZYM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amyris Inc $1.56 USD -0.10
Gevo Inc $1.41 USD -0.02
Wessanen €9.48 EUR +0.151
Pacific Ethanol Inc $4.12 USD -0.185
Renewable Energy Group Inc $8.46 USD +0.04
View Industry Companies

Industry Analysis


Industry Average

Valuation SZYM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SOLAZYME INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at